Global EditionASIA 中文双语Français
Home / China / Innovation

Scientists identify new gene behind rare blood disease

Xinhua | Updated: 2022-08-31 09:54
Share - WeChat

BEIJING -- Chinese scientists have identified a new gene, the deficiency of which may lead to a rare, life-threatening blood disease called hemophagocytic lymphohistiocytosis (HLH).

The illness typically occurs in early childhood, with stem cell transplantation being the only definitive curative therapy. Previous studies have found 12 risk genes, but they can explain only a small proportion of the HLH cases.

Now a new study, the findings of which were published in the Journal of Hematology & Oncology, may help doctors to screen the high-risk populations of the genetic disease and raise the early diagnosis and treatment rate.

Using whole-genome sequencing technology, researchers from the Beijing Institute of Genomics under the Chinese Academy of Sciences and Beijing Children's Hospital of the Capital Medical University, identified a novel gene called NBAS in Chinese patients with HLH.

According to the study, which covered 237 cases, the estimated frequency of NBAS variants among the child patients was 2.11 percent, making it the second most frequently mutated gene. The first one called PRF1 has a mutation rate of 3.8 percent.

The research is the latest example of China's intensified research efforts to rescue millions of patients with rare diseases in the country.

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349